Severe Asthma

Also known as: Severe asthma (disorder)

DrugDrug NameDrug Description
DB00443BetamethasoneA systemic corticosteroid used to relieve inflammation in various conditions, including but not limited to allergic states, dermatologic disorders, gastrointestinal diseases, and hematological disorders.
DB12159DupilumabA monoclonal antibody used to treat moderate to severe atopic dermatitis, asthma, and nasal polyps accompanied by chronic rhinosinusitis in adolescents and adults.
DB00668EpinephrineA hormone and neurotransmitter used to treat allergic reactions, to restore cardiac rhythm, and to control mucosal congestion, glaucoma, and asthma.
DB00043OmalizumabA monoclonal anti-immunoglobulin E (IgE) antibody used to treat asthma, chronic idiopathic urticaria, chronic rhinosinusitis with nasal polyps, and IgE-mediated food allergy.
DB00860PrednisoloneA glucocorticoid used to treat adrenocortical insufficiency, inflammatory conditions, and some cancers.
DB15090TezepelumabA human monoclonal IgG2λ thymic stromal lymphopoietin (TSLP)-blocking antibody for add-on maintenance therapy in severe asthma.
DrugDrug NameTargetType
DB00443BetamethasoneGlucocorticoid receptortarget
DB00443BetamethasoneCytochrome P450 3A4enzyme
DB00443BetamethasoneP-glycoprotein 1transporter
DB00443BetamethasoneCytochrome P450 19A1enzyme
DB00443BetamethasoneCytochrome P450 3A5enzyme
DB00443BetamethasoneCytochrome P450 3A7enzyme
DB00443BetamethasoneCytochrome P450 2A6enzyme
DB00443BetamethasoneCytochrome P450 1B1enzyme
DB00443BetamethasoneCytochrome P450 2B6enzyme
DB00443BetamethasoneCytochrome P450 2C8enzyme
DB00443BetamethasoneCytochrome P450 2C9enzyme
DB00443BetamethasoneCytochrome P450 2C19enzyme
DB00443BetamethasoneSerum albumincarrier
DB00443BetamethasoneCorticosteroid-binding globulincarrier
DB12159DupilumabInterleukin-4 receptor subunit alphatarget
DB12159DupilumabInterleukin-13target
DB12159DupilumabInterleukin-4target
DB00668EpinephrineAlpha-1A adrenergic receptortarget
DB00668EpinephrineBeta-1 adrenergic receptortarget
DB00668EpinephrineBeta-2 adrenergic receptortarget
DB00668EpinephrineSolute carrier family 22 member 2transporter
DB00668EpinephrineSolute carrier family 22 member 1transporter
DB00668EpinephrineCytochrome P450 2C9enzyme
DB00668EpinephrineCytochrome P450 3A4enzyme
DB00668EpinephrineAlpha-1B adrenergic receptortarget
DB00668EpinephrineAlpha-1D adrenergic receptortarget
DB00668EpinephrineAlpha-2A adrenergic receptortarget
DB00668EpinephrineAlpha-2B adrenergic receptortarget
DB00668EpinephrineTumor necrosis factortarget
DB00668EpinephrineCatechol O-methyltransferaseenzyme
DB00668EpinephrineMonoamine oxidaseenzyme
DB00043OmalizumabImmunoglobulin heavy constant epsilontarget
DB00860PrednisoloneCorticosteroid-binding globulincarrier
DB00860PrednisoloneCytochrome P450 3A4enzyme
DB00860PrednisoloneGlucocorticoid receptortarget
DB00860PrednisoloneSolute carrier organic anion transporter family member 1A2transporter
DB00860PrednisoloneP-glycoprotein 1transporter
DB00860PrednisoloneSerum albumincarrier
DB15090TezepelumabThymic stromal lymphopoietintarget
DrugDrug NamePhaseStatusCount
DB15090TezepelumabNot AvailableRecruiting1
DB06612Mepolizumab1Completed1
DB06602Reslizumab2Completed1
DB00641Simvastatin2Withdrawn1
DB19096Verekitug2Recruiting1
DB01001Albuterol3Not Yet Recruiting1
DB01222Budesonide3Not Yet Recruiting1
DB00983Formoterol3Not Yet Recruiting1
DB00742Mannitol3Not Yet Recruiting1
DB15090Tezepelumab3Completed1
DB15090Tezepelumab3Not Yet Recruiting1
DB12023Benralizumab4Recruiting1
DB12023Benralizumab4Withdrawn1
DB01175Escitalopram4Completed1
DB06612Mepolizumab4Recruiting1
DB00043Omalizumab4Recruiting1
DB12023BenralizumabNot AvailableCompleted1
DB12159DupilumabNot AvailableCompleted2
DB06612MepolizumabNot AvailableActive Not Recruiting1
DB06612MepolizumabNot AvailableCompleted2
DB06612MepolizumabNot AvailableRecruiting1